Agencies
Services
Drugs and Therapeutics (D & T) Committee Drugs Under Review for: June 19, 2013
| Drug Name | Review Type | Class | Manufacturer |
|---|---|---|---|
| Invokana | New Drug Initial Review | SGLT2 Inhibitor | Janssen |
| Pertzye | New Drug Initial Review | Pancreatic Enzyme | Digestive Care, Inc |
| Vascepa | New Drug Initial Review | Lipotropic | Amarin |
| Myrbetriq | New Drug Initial Review | Urinary Anti-Incontinence Agent | Astellas Pharma |
| Tecfidera | New Drug Initial Review | Multiple Sclerosis | Biogen Idec |
| Nesina | New Drug Initial Review | DPP-4 Inhibitor | Takeda |
| Diclegis | New Drug Initial Review | Antiemetic | Duchesnay USA |
| Tradjenta | New Drug Appeal | DPP-4 Inhibitor | Boehringer-Ingelheim |
| Tudorza Pressair | New Drug Appeal | Long Acting Anticholingergic | Forest |
| Stribild | New Drug Appeal | HIV/AIDS | Gilead |
| Humatrope | PDL Appeal | Growth Hormone | Eli Lilly |